Advanced search
Publication Cover
Cancer Biology & Therapy Volume 13, 2012 - Issue 14
Submit an article Journal homepage
1,809
Views
70
CrossRef citations to date
0
Altmetric
Review

Rapalogs in cancer prevention

Anti-aging or anticancer?

Mikhail V. Blagosklonny Department of Cell Stress Biology; Roswell Park Cancer Institute; Buffalo, NY USACorrespondence[email protected]
Pages 1349-1354 | Received 12 Nov 2012, Accepted 12 Nov 2012, Published online: 14 Nov 2012

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Chuanbing Zang, Jan Eucker, Piet Habbel, Christian Neumann, Carsten-Oliver Schulz, Nikola Bangemann, Lutz Kissner, Hanno Riess & Hongyu Liu. (2015) Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. Cell Cycle 14:8, pages 1291-1299.
Read now
Irina G Popovich, Vladimir N Anisimov, Mark A Zabezhinski, Anna V Semenchenko, Margarita L Tyndyk, Maria N Yurova & Mikhail V Blagosklonny. (2014) Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin. Cancer Biology & Therapy 15:5, pages 586-592.
Read now
JAVIERABEL MENENDEZ MENENDEZ, TOMÁS ALARCÓN & Jorge Joven. (2014) Gerometabolites: The pseudohypoxic aging side of cancer oncometabolites. Cell Cycle 13:5, pages 699-709.
Read now
Mikhail V Blagosklonny. (2013) Immunosuppressants in cancer prevention and therapy. OncoImmunology 2:12.
Read now
Mikhail V Blagosklonny. (2013) Selective anti-cancer agents as anti-aging drugs. Cancer Biology & Therapy 14:12, pages 1092-1097.
Read now
Olga V Leontieva, Liliya R Novototskaya, Geraldine M Paszkiewicz, Elena A Komarova, Andrei V Gudkov & Mikhail V Blagosklonny. (2013) Dysregulation of the mTOR pathway in p53-deficient mice. Cancer Biology & Therapy 14:12, pages 1182-1188.
Read now

Articles from other publishers (64)

Poppy Diah Palupi, Mohammed Safwan Ali Khan & Nur Dina Amalina. 2023. Immunosuppression and Immunomodulation. Immunosuppression and Immunomodulation.
Hui Ying, Zhi-Qiang Li, Meng-Pan Li & Wen-Cai Liu. (2023) Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies. Frontiers in Endocrinology 14.
Crossref
Josué Ballesteros-Álvarez, Wynnie Nguyen, Renuka Sivapatham, Anand Rane & Julie K. Andersen. (2022) Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease. GeroScience 45:2, pages 1095-1113.
Crossref
Josué Ballesteros‐Álvarez & Julie K. Andersen. (2021) mTORC2: The other mTOR in autophagy regulation. Aging Cell 20:8.
Crossref
Anna Chmurska, Karolina Matczak & Agnieszka Marczak. (2021) Two Faces of Autophagy in the Struggle against Cancer. International Journal of Molecular Sciences 22:6, pages 2981.
Crossref
María B. Birkisdóttir, Dick Jaarsma, Renata M. C. Brandt, Sander Barnhoorn, Nicole Vliet, Sandra Imholz, Conny T. Oostrom, Bhawani Nagarajah, Eliana Portilla Fernández, Anton J. M. Roks, Ype Elgersma, Harry Steeg, José A. Ferreira, Jeroen L. A. Pennings, Jan H. J. Hoeijmakers, Wilbert P. Vermeij & Martijn E. T. Dollé. (2021) Unlike dietary restriction, rapamycin fails to extend lifespan and reduce transcription stress in progeroid DNA repair‐deficient mice. Aging Cell 20:2.
Crossref
Chao‐Yen Ho, An‐Chen Chang, Chung‐Hua Hsu, Te‐Fu Tsai, Yi‐Chia Lin, Kuang‐Yu Chou, Hung‐En Chen, Ji‐Fan Lin, Po‐Chun Chen & Thomas I‐Sheng Hwang. (2020) Miconazole induces protective autophagy in bladder cancer cells. Environmental Toxicology 36:2, pages 185-193.
Crossref
Chul Won Yun, Juhee Jeon, Gyeongyun Go, Jun Hee Lee & Sang Hun Lee. (2020) The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy. International Journal of Molecular Sciences 22:1, pages 179.
Crossref
Mahendra Kumar Sahu, Komal Kaushik, Amitava Das & Harit Jha. (2020) In vitro and in silico antioxidant and antiproliferative activity of rhizospheric fungus Talaromyces purpureogenus isolate-ABRF2. Bioresources and Bioprocessing 7:1.
Crossref
Yuri Shchegolev, Danila Sorokin, Alexander Scherbakov, Alexey Shunaev, Olga Andreeva, Ekaterina Mikhaevich, Margarita Gudkova, Irina Bure, Lev Berstein, Marina Nemtsova & Mikhail Krasil'nikov. (2020) Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells. Chemico-Biological Interactions 330, pages 109243.
Crossref
Sarah Lapointe, Warren Mason, Mary MacNeil, Craig Harlos, Roger Tsang, Joana Sederias, H. Artee Luchman, Samuel Weiss, John P. Rossiter, Dongsheng Tu, Lesley Seymour & Martin Smoragiewicz. (2019) A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study. Investigational New Drugs 38:4, pages 1137-1144.
Crossref
Xuedan Sun, Rick Francis Thorne, Xu Dong Zhang, Miao He, Jinming Li, Shanshan Feng, Xiaoying Liu & Mian Wu. (2020) Lnc RNA GUARDIN suppresses cellular senescence through a LRP 130‐ PGC 1α‐ FOXO 4‐p21‐dependent signaling axis . EMBO reports 21:4.
Crossref
Avaniyapuram Kannan Murugan. (2019) mTOR: Role in cancer, metastasis and drug resistance. Seminars in Cancer Biology 59, pages 92-111.
Crossref
Marniker Wijesinha, Jon Mark Hirshon, Michael Terrin, Laurence Magder, Clayton Brown, Kristen Stafford & Aldo Iacono. (2019) Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant. JAMA Network Open 2:8, pages e1910297.
Crossref
Irene de Diego, Shahaf Peleg & Beate Fuchs. (2019) The role of lipids in aging-related metabolic changes. Chemistry and Physics of Lipids 222, pages 59-69.
Crossref
Veronika Piskovatska, Olha Strilbytska, Alexander Koliada, Alexander Vaiserman & Oleh Lushchak. 2019. Biochemistry and Cell Biology of Ageing: Part II Clinical Science. Biochemistry and Cell Biology of Ageing: Part II Clinical Science 339 392 .
M. N. Yurova, D. R. Safina & I. V. Mizgirev. (2018) SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO. Advances in molecular oncology 5:2, pages 42-49.
Crossref
Maria Russo & Gian Luigi Russo. (2018) Autophagy inducers in cancer. Biochemical Pharmacology 153, pages 51-61.
Crossref
Veronika Piskovatska, Olha Strilbyska, Kenneth B. Storey, Alexander M. Vaiserman & Oleh Lushchak. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Olga V. Leontieva & Mikhail V. Blagosklonny. (2017) While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts. Oncotarget 8:65, pages 109848-109856.
Crossref
Mikhail V. Blagosklonny. (2017) From rapalogs to anti-aging formula. Oncotarget 8:22, pages 35492-35507.
Crossref
Preety Bajwa, Subhransu S. Sahoo & Pradeep S. Tanwar. (2017) Age-related mTOR in gynaecological cancers. Aging 9:2, pages 301-302.
Crossref
María Rico, María Baglioni, Maryna Bondarenko, Nahuel Cesatti Laluce, Viviana Rozados, Nicolas André, Manon Carré, O. Graciela Scharovsky & Mauricio Menacho Márquez. (2016) Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models. Oncotarget 8:2, pages 2874-2889.
Crossref
A.M. Vaiserman. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 349 378 .
Alexander M. Vaiserman, Oleh V. Lushchak & Alexander K. Koliada. (2016) Anti-aging pharmacology: Promises and pitfalls. Ageing Research Reviews 31, pages 9-35.
Crossref
Jin Zining, Xu Lu, He Caiyun & Yuan Yuan. (2016) Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis . Oncotarget 7:35, pages 57464-57480.
Crossref
Ghim Siong Ow, Zhiqun Tang & Vladimir A. Kuznetsov. (2016) Big data and computational biology strategy for personalized prognosis. Oncotarget 7:26, pages 40200-40220.
Crossref
Hua Liang, Zhengmao Zhang, Liqun He & Yanlin Wang. (2016) CXCL16 regulates cisplatin-induced acute kidney injury. Oncotarget 7:22, pages 31652-31662.
Crossref
Preety Bajwa, Prathima B. Nagendra, Sarah Nielsen, Subhransu S. Sahoo, Amanda Bielanowicz, Janine M. Lombard, J. Erby Wilkinson, Richard A. Miller & Pradeep S. Tanwar. (2016) Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium. Oncotarget 7:15, pages 19214-19227.
Crossref
Ergul Dilan Celebi-Birand, Elif Tugce Karoglu, Fusun Doldur-Balli & Michelle M. Adams. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR 185 203 .
Anatoliy I. Yashin, Eric Stallard & Kenneth C. LandAnatoliy I. Yashin, Igor Akushevich, Konstantin G. Arbeev, Alexander M. Kulminski & Svetlana V. Ukraintseva. 2016. Biodemography of Aging. Biodemography of Aging 331 352 .
Alexander Zhavoronkov. (2015) Inhibitors of mTOR in aging and cancer. Oncotarget 6:42, pages 45010-45011.
Crossref
Noriko N. Yokoyama, Andria P. Denmon, Edward M. Uchio, Mark Jordan, Dan Mercola & Xiaolin Zi. (2015) When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?. Current Pharmacology Reports 1:6, pages 420-433.
Crossref
Helga Weber, Pamela Leal, Stefan Stein, Hana Kunkel, Patricia García, Carolina Bizama, Jaime A. Espinoza, Ismael Riquelme, Bruno Nervi, Juan C. Araya, Manuel Grez & Juan C. Roa. (2015) Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice. Oncotarget 6:31, pages 31877-31888.
Crossref
Chung-Ji Liu, Wan-Jung Chang, Chang-Yi Chen, Fang-Ju Sun, Hui-Wen Cheng, Tsai-Ying Chen, Shu-Chun Lin & Wan-Chun Li. (2015) Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis. Oncotarget 6:30, pages 29268-29284.
Crossref
Olga V. Leontieva, Zoya N. Demidenko & Mikhail V. Blagosklonny. (2015) Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program). Oncotarget 6:27, pages 23238-23248.
Crossref
Wenhua Li, Jinjia Chang, Shanshan Wang, Xinyang Liu, Junjie Peng, Dan Huang, Menghong Sun, Zhiyu Chen, Wen Zhang, Weijian Guo & Jin Li. (2015) miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget 6:27, pages 24448-24462.
Crossref
Jong Kyu Woo, Ju-Hee Kang, BoRa Kim, Byung Hee Park, Kum-Joo Shin, Seong-Won Song, Jung Ju Kim, Hwan-Mook Kim, Sang-Jin Lee & Seung Hyun Oh. (2015) Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF. Oncotarget 6:27, pages 24047-24060.
Crossref
Benling Xu, Long Yuan, Quanli Gao, Peng Yuan, Peng Zhao, Huijuan Yuan, Huijie Fan, Tiepeng Li, Peng Qin, Lu Han, Weijia Fang & Zhenhe Suo. (2015) Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer. Oncotarget 6:24, pages 20592-20603.
Crossref
Mikhail V. Blagosklonny. (2015) Rejuvenating immunity: “anti-aging drug today” eight years later. Oncotarget 6:23, pages 19405-19412.
Crossref
Arindam P. Ghosh, Christopher B. Marshall, Tatjana Coric, Eun-hee Shim, Richard Kirkman, Mary E. Ballestas, Mitsuhiko Ikura, Mary-Ann Bjornsti & Sunil Sudarshan. (2015) Point mutations of the mTOR-RHEB pathway in renal cell carcinoma. Oncotarget 6:20, pages 17895-17910.
Crossref
Encheng Li, Zhiyun Xu, Hui Zhao, Zhao Sun, Lei Wang, Zhe Guo, Yang Zhao, Zhancheng Gao & Qi Wang. (2015) Macrophages promote benzopyrene-induced tumor transformation of human bronchial epithelial cells by activation of NF-κB and STAT3 signaling in a bionic airway chip culture and in animal models. Oncotarget 6:11, pages 8900-8913.
Crossref
Xiaochun Yang, Jincheng Wang, Jiabin Dai, Jinjin Shao, Jian Ma, Chao Chen, Shenglin Ma, Qiaojun He, Peihua Luo & Bo Yang. (2015) Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling. Oncotarget 6:8, pages 6203-6217.
Crossref
Jorge Iván Castillo-Quan, Kerri J. Kinghorn & Ivana Bjedov. 2015. 1 101 .
Olga V. Leontieva & Mikhail V. Blagosklonny. (2014) Gerosuppression in confluent cells. Aging 6:12, pages 1010-1018.
Crossref
Olga V. Leontieva & Mikhail V. Blagosklonny. (2014) Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion. Oncotarget 5:24, pages 12715-12727.
Crossref
M V Blagosklonny. (2014) Koschei the immortal and anti-aging drugs. Cell Death & Disease 5:12, pages e1552-e1552.
Crossref
Dan Ehninger, Frauke Neff & Kan Xie. (2014) Longevity, aging and rapamycin. Cellular and Molecular Life Sciences 71:22, pages 4325-4346.
Crossref
Burhan Hassan, Argun Akcakanat, Takafumi Sangai, Kurt W. Evans, Farrell Adkins, Agda Karina Eterovic, Hao Zhao, Ken Chen, Huiqin Chen, Kim-Anh Do, Shelly M. Xie, Ashley M. Holder, Aung Naing, Gordon B. Mills & Funda Meric-Bernstam. (2014) Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget 5:18, pages 8544-8557.
Crossref
Bruna Corominas-Faja, Elvira Santangelo, Elisabet Cuyàs, Vicente Micol, Jorge Joven, Xavier Ariza, Antonio Segura-Carretero, Jordi García & Javier A. Menendez. (2014) Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins. Aging 6:9, pages 731-741.
Crossref
Anton A. Buzdin, Alex A. Zhavoronkov, Mikhail B. Korzinkin, Sergey A. Roumiantsev, Alexander M. Aliper, Larisa S. Venkova, Philip Y. Smirnov & Nikolay M. Borisov. (2014) The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis. Frontiers in Molecular Biosciences 1.
Crossref
Zbigniew Darzynkiewicz, Hong Zhao, H. Dorota Halicka, Jiangwei Li, Yong-Syu Lee, Tze-Chen Hsieh & Joseph M. Wu. (2014) In search of antiaging modalities: Evaluation of mTOR- and ROS/DNA damage-signaling by cytometry. Cytometry Part A 85:5, pages 386-399.
Crossref
Tatiana V. Pospelova & Valery A. Pospelov. (2014) Latest progress in tyrosine kinase inhibitors. Oncotarget 5:5, pages 1157-1161.
Crossref
Vivek Subbiah, Robert E. BrownMary F. McGuireJamie BuryanekFilip Janku, Anas Younes & David Hong. (2013) A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma. Oncotarget 5:1, pages 95-102.
Crossref
M V Blagosklonny. (2013) TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death & Disease 4:12, pages e964-e964.
Crossref
Michael Y. Sherman & Shu-Bing Qian. (2013) Less is more: improving proteostasis by translation slow down. Trends in Biochemical Sciences 38:12, pages 585-591.
Crossref
Hong Zhao, H Dorota Halicka, Jiangwei Li & Zbigniew Darzynkiewicz. (2013) Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging 5:8, pages 623-636.
Crossref
Mikhail V. Blagosklonny. (2013) Rapamycin extends life- and health span because it slows aging. Aging 5:8, pages 592-598.
Crossref
Mikhail V. Blagosklonny. (2013) Big mice die young but large animals live longer. Aging 5:4, pages 227-233.
Crossref
Yueyong Liu, Yurong Huang, Zeran Wang, Yong Huang, Xiaohua Li, Alexander Louie, Guangwei Wei & Jian-Hua Mao. (2013) Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development. Aging 5:2, pages 111-119.
Crossref
Matt Kaeberlein. (2013) mTOR Inhibition: From Aging to Autism and Beyond. Scientifica 2013, pages 1-17.
Crossref
Mikhail V. Blagosklonny. (2012) Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget 3:12, pages 1711-1724.
Crossref
Caroline Bret, Bernard Klein & Jérôme Moreaux. (2012) Gene expression-based risk score in diffuse large B-cell lymphoma. Oncotarget 3:12, pages 1700-1710.
Crossref
James A. McCubrey & Zoya N. Demidenko. (2012) Recent discoveries in the cycling, growing and aging of the p53 field. Aging 4:12, pages 887-893.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.